Metopirone (Metyrapone)

Metyrapone works by selectively blocking the enzyme 11β‑hydroxylase (CYP11B1) in the adrenal cortex. This inhibition prevents the final step of cortisol production, leading to reduced cortisol output, a rise in ACTH, and accumulation of steroid precursors. The resulting hormonal changes are useful for both diagnostic assessment and, in certain cases, therapeutic reduction of cortisol.

The dosage of Metopirone is individualized and must be determined by a qualified prescriber based on the specific clinical indication, patient characteristics, and laboratory monitoring. Physicians consider factors such as the purpose of testing, severity of disease, and concurrent medications when setting the appropriate dose.

Safety data for Metopirone during pregnancy and lactation are limited, and the product’s pregnancy category has not been established. Healthcare providers should evaluate the potential benefits against possible risks before prescribing to pregnant or nursing women, and consider alternative diagnostic or therapeutic options when appropriate.

To request Metopirone, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and assistance with import documentation.

The most common alternative class for adrenal steroidogenesis inhibition includes ketoconazole and levoketoconazole. Compared with ketoconazole, metyrapone has a more selective mechanism targeting 11β‑hydroxylase, which may result in a different side‑effect profile, particularly less hepatotoxicity. However, ketoconazole may provide broader inhibition of steroid synthesis, and the choice depends on clinical goals, patient tolerance, and regulatory approvals.

Metopirone tablets should be stored at ambient temperature, preferably below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and avoid storing in areas with high humidity or direct sunlight to maintain potency.

Metopirone is taken orally, usually as a tablet swallowed whole with a glass of water. The prescriber will indicate whether the dose should be taken with food or on an empty stomach, and the timing relative to other medications may be specified to optimize absorption and minimize interactions.

Serious risks associated with Metopirone include the development of hypertension, adrenal crisis due to abrupt cortisol deficiency, and severe allergic reactions such as rash, swelling, or breathing difficulties. Patients should seek immediate medical attention if they experience sudden high blood pressure, signs of shock, or any signs of an allergic response.

Metopirone is contraindicated in individuals with known hypersensitivity to metyrapone or any of its excipients, and in patients with uncontrolled hypertension. Caution is also advised for those with severe hepatic impairment, electrolyte disturbances, or active infections, as the drug may exacerbate these conditions. A prescriber should evaluate each patient’s medical history before initiating therapy.